101. Serious Adverse Event Rates for Cefazolin and Ceftriaxone Outpatient Parenteral Antimicrobial Therapy

BACKGROUND: Beta-lactams are thought to be well-tolerated in outpatient parenteral antimicrobial therapy (OPAT), but few studies address the utility of regularly monitoring laboratory parameters for beta-lactams in the OPAT setting. Our aim was to assess OPAT adverse event (AE) rates for cefazolin a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sunagawa, Shawnalyn, Arduser, Sarah, Miller, Molly M, Lyden, Elizabeth, Cortes-Penfield, Nicolas W, Hankins, Richard, Bergman, Scott J, Alexander, Bryan T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677063/
http://dx.doi.org/10.1093/ofid/ofad500.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677063/
http://dx.doi.org/10.1093/ofid/ofad500.017

Ejemplares similares